Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
45.75
-1.32 (-2.80%)
Mar 9, 2026, 3:04 PM CST

SHE:002653 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
50,74936,88325,54523,69521,74718,638
Market Cap Growth
49.02%44.38%7.81%8.96%16.68%-14.41%
Enterprise Value
51,66337,65826,25625,22722,52119,066
Last Close Price
45.7533.0022.7221.8419.7916.76
PE Ratio
167.3093.2786.5685.5263.0229.28
Forward PE
97.3458.2062.9969.5362.7723.76
PS Ratio
11.889.917.617.867.845.60
PB Ratio
12.018.786.137.567.456.53
P/TBV Ratio
19.0112.567.4510.1810.078.10
P/FCF Ratio
223.2926513.20436.15---
P/OCF Ratio
79.8883.4456.82250.62607.4390.39
EV/Sales Ratio
12.1010.127.838.378.125.73
EV/EBITDA Ratio
106.2775.5748.2479.50122.4457.27
EV/EBIT Ratio
231.82143.7279.19178.20598.9883.50
EV/FCF Ratio
227.3127070.49448.29---
Debt / Equity Ratio
0.550.460.430.670.430.38
Debt / EBITDA Ratio
4.773.763.286.486.553.23
Debt / FCF Ratio
10.211373.2830.84---
Net Debt / Equity Ratio
0.220.170.120.430.23-0.06
Net Debt / EBITDA Ratio
1.921.410.884.213.67-0.48
Net Debt / FCF Ratio
4.03506.238.16-2.21-1.010.40
Asset Turnover
0.610.550.530.550.560.66
Inventory Turnover
4.103.843.103.053.915.17
Quick Ratio
1.571.481.501.090.811.04
Current Ratio
1.761.741.761.381.021.22
Return on Equity (ROE)
7.36%11.14%8.09%12.94%17.93%22.98%
Return on Assets (ROA)
1.97%2.44%3.26%1.60%0.47%2.84%
Return on Invested Capital (ROIC)
4.29%5.49%7.11%3.51%1.20%8.08%
Return on Capital Employed (ROCE)
4.10%5.00%6.40%3.10%1.10%7.00%
Earnings Yield
0.61%1.07%1.16%1.17%1.59%3.42%
FCF Yield
0.45%0.00%0.23%-2.56%-3.07%-2.12%
Dividend Yield
0.88%1.26%0.88%-0.94%2.22%
Payout Ratio
108.47%106.72%14.43%89.32%123.52%20.54%
Buyback Yield / Dilution
-2.50%-3.37%-2.57%1.17%0.07%-0.50%
Total Shareholder Return
-1.62%-2.11%-1.69%1.17%1.00%1.72%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.